AstraZeneca Shares Hit Record High After Earnings Beat, U.S. Price Deal -- Market Talk

Dow Jones
2025/11/11

1338 GMT - AstraZeneca shares hit their highest level on record after third-quarter earnings last week beat market expectations. A U.S. drug-pricing deal reached last month that eased policy uncertainty also supports gains for the British pharma group, which makes more than 40% of its sales in the U.S. Shares rose 2.5% in early trading after climbing to an all-time intraday high of 134.6 pounds. Shares are now trading at 133.48 pounds, valuing the company at 203.3 billion pounds. AstraZeneca remains the largest U.K.-listed stock by market capitalization. (william.gray@wsj.com)

 

(END) Dow Jones Newswires

November 11, 2025 08:38 ET (13:38 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10